Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults
Graft-versus-host disease (GvHD) in its acute and chronic forms continues to represent a significant barrier to the success and wide-applicability of blood and marrow transplantation as a potentially curative treatment modality for a number of benign and malignant blood conditions. Presently, calcin...
Main Authors: | Cosmin Tegla, Jun Choi, Maher Abdul-Hay, Frank Cirrone, Kelli Cole, A Samer Al-Homsi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAABRON PRESS
2020-01-01
|
Series: | Clinical Hematology International |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125932843/view |
Similar Items
-
Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression
by: Amanda Reyes, et al.
Published: (2022-12-01) -
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study
by: Elisabetta Xue, et al.
Published: (2022-02-01) -
Non-melanoma skin cancer outcomes in kidney
transplant recipients converted from calcineurin
inhibitors to mTOR inhibitors: a systematic review
by: Berenika Olszewska, et al.
Published: (2023-06-01) -
Development of murine model of allogeneic bone marrow transplantation and graft-versus-host disease
by: I. S. Moiseev, et al.
Published: (2016-12-01) -
Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)